Article

Second-quarter merger predicted for AMO, VISX

Santa Ana, CA—The merger of Advanced Medical Optics Inc. (AMO) and VISX Inc. is taking a little longer to complete than anticipated, as auditors work to finish the companies' year-end financial statements.

Santa Ana, CA-The merger of Advanced Medical Optics Inc. (AMO) and VISX Inc. is taking a little longer to complete than anticipated, as auditors work to finish the companies' year-end financial statements.

The companies expect to finalize the merger during the second quarter of this year, despite earlier predictions that it would happen during the first quarter. The companies attributed the delay to securities laws that now require financial statements to be included in their joint proxy statement/prospectus, which is mailed to stockholders prior to their respective stockholder meetings.

Meanwhile, AMO is taking a page from the VISX book and bolstering its customer service by hiring in-house field service engineers.

At the time of the merger, AMO said it would like to incorporate VISX's emphasis on customer service.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
1 expert is featured in this series.
© 2025 MJH Life Sciences

All rights reserved.